NGVB Publications

Peters, B., Discherl. S., Dantzer, J., Nowacki, N., Cross S., Cornetta, K., Dinauer, M.C., and Mooney SD. Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource. Gene Ther.15:1294-8, 2008. PMC2766545

Cornetta, K., Matheson, L. The National Gene Vector Biorepository Pharm/Tox Database. Mol. Ther. 17(4):582-4. 2009. PMC2835100.

Cornetta, K., Yao J., Jasti A., Koop, S., Douglas, M., Hsu, D., Couture, L. A., Hawkins, T., Duffy, L. Replication Competent Lentivirus Analysis of Clinical Grade Vector Products. Mol Ther.19:557-66, 2011. PMC3048188.

Hawkins, T. B., Danzer, J., Peters, B., Dinauer, M. C., Mockaitis, K., Mooney, S., Cornetta, K. Identifying viral integration sites using SeqMap 2.0. Bioinformatics. 27:720-2, 2011. PMC3042184

Leath, A., and Cornetta, K. Developing novel lentiviral vectors into clinical products. Methods in Enzymology, 507:89-108, 2012. PMID: 22365770

Aloia, A., Duffy, L., Pak, V., Lee, K., Sanchez-Martinez, S., Derse, D., Heidecker, G., Cornetta, K., and Rein, A. A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay. Gene Therapy 20:169-176, 2013. PMC 3374051

Boeke, A., Dumas, P., Reeves, L., McClurg, K., Bischof, D., Sego, L., Auberry, A., Tatikonda, M., Cornetta, K. Vector Production in An Academic Environment: A Tool to Assess Production Costs. Human Gene Therapy Methods. 24: 49-57, 2013. PMC4015083

Cornetta, K., Tessanne, K., Long, C., Yao, J., Satterfield, C., Westhusin, M. Transgenic sheep generated by lentiviral vectors: Safety and integration analysis of surrogates and their offspring. Transgenic Research 22:737-45, 2013. PMC3606283

Shaw, A., and Cornetta, K. Design and Potential of Non-Integrating Lentiviral Vectors. Biomedicines 2014, 2, 14-35. PMC5423482

Gao, H., Hawkins, T., Jasti, A., Chen, Y.H., Mockaitis, K., Dinauer, M., Cornetta, K. Development and Evaluation of Quality Metrics for Bioinformatics Analysis of Viral Insertion Site Data Generated Using High Throughput Sequencing. Biomedicines 2014, 2(2), 195-210; doi:10.3390/biomedicines2020195, PMC5423470

Shaw, A. M., Joseph, G. L., Jasti, A. C., Sastry-Dent, L., Witting, S., Cornetta, K. Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors. Gene Ther. 24, 12–20, 2017. PMC5269419

Cornetta, K., Duffy, L., Turtle, C.J., Jensen, M., Forman, S., Binder-Scholl, G. Fry, T., Chew, A., Maloney, D. G., and June, C.H. Absence of Replication Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products. Molecular Therapy 28:280-288, 2018. Epub 2017 PMC5762981

Cornetta, K., Duffy, L., Feldman, S.A., , Mackall, C.A., Davila, M.L., Curran, K.J., Junghans, R.P., Tang, J.Y., James Kochenderfer, J., O’Cearbhaill, R., Archer, G., Kiem, H-P., Shah, N.L., Delbrook, C., Kaplan, R., Brentjens, R. J., Riviére, I., Sadelein, M., and Rosenberg, S.A. Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience. Molecular Therapy: Methods & Clinical Development (2018) https://doi/org/10.1016/j.omtm.2018.08.006 PMC6134358

Cornetta, K., Matheson, L., Long, R., Duffy, L. The National Gene Vector Biorepository. Eleven Years of Providing Resources to the Gene Therapy Community. Human Gene Therapy: 31, 145-150.